NCT06790498Enrolling by invitation
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
A Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy From Studies REGEN-006, REGEN-007, and REGEN-015 (REGEN-008S2)
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the long-term safety, efficacy, and durability in participants with chronic kidney disease (CKD) who received up to four REACT injections, delivered percutaneously into either the same or bilateral kidneys in previous studies.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 14 Jan 2025
- Start date
- 23 Nov 2023
- Primary completion date
- 31 May 2030
- Lead sponsor
- Prokidney
- Diseases
- Chronic kidney disease
- NCT number
- NCT06790498
What you commit to
- Study type: Observational
- Planned participants: 50
- From 23 Nov 2023 to the primary completion date, 31 May 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant did not receive REACT in a previous trial for the treatment of chronic kidney disease
Who the study is looking for
- The participant must have received REACT in a previous trial (REGEN-006, REGEN- 007, and REGEN-015) for the treatment of chronic kidney disease and completed an end of study visit in their previous trial per protocol.
- The participant is willing and able to cooperate with all aspects of the protocol.
- The participant is willing and able to provide signed informed consent.
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boise Kidney & Hypertension Institute Coordinator of this site? Confirm its status | Meridian | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.